New Heart Guidelines Could Help 29 Million More Americans

Nearly 30 million more Americans just became eligible for cholesterol-lowering medications that could prevent heart attacks and strokes before they happen.

In March 2026, the American Heart Association and American College of Cardiology released updated guidelines that expanded treatment eligibility from 41% to 55% of adults without existing heart disease. That's a 13-point jump that could save countless lives through earlier prevention.

The new guidelines use a smarter risk calculator called PREVENT that considers kidney function and current medications, factors the old system ignored. It also removed race as a calculation factor, making assessments more personalized and equitable.

Researchers at Epic Research studied over 21 million patient records to see who the changes would affect most. They found that nearly 14% of adults gained eligibility, while only 0.6% lost it, making this an overwhelming expansion rather than a reshuffling of who qualifies.

Women were the biggest winners in the update. They made up 66% of newly eligible patients despite representing only 58% of the study population overall.

Older adults also saw dramatic gains. People aged 70 to 79 made up 36% of those who gained eligibility, even though they represent just 16% of the population, thanks to the guideline extending the eligible age range from 75 to 79.

The guidelines also elevated chronic kidney disease and HIV from risk modifiers to standalone qualifying conditions. This change recognizes what research has shown: these conditions significantly increase heart disease risk regardless of other factors.

Every demographic group studied saw net increases in eligibility, including men, Black patients, and middle-aged adults. Even groups that had some members lose eligibility still gained overall access to preventive treatment.

The Ripple Effect

High cholesterol causes heart attacks and strokes, which remain leading killers in America. Statins and other cholesterol medications are proven, affordable treatments that can prevent these events before they happen.

When national guidelines change, they ripple through doctor's offices nationwide, opening conversations between millions of patients and their physicians about starting preventive treatment. These aren't experimental therapies but well-studied medications that have prevented cardiovascular events for decades.

The shift to more inclusive guidelines means more people, especially women and older adults who've historically been undertreated for heart disease, will have the chance to protect their health proactively. Preventive care is always better than emergency care.

This expansion represents a fundamental shift in how medicine thinks about prevention: casting a wider net to catch problems before they become crises, and using better tools to identify who needs help.